Literature DB >> 8781140

Altered myocardial perfusion during dobutamine stress testing in silent versus symptomatic myocardial ischaemia assessed by quantitative MIBI SPET imaging.

A Elhendy1, M L Geleijnse, J R Roelandt, J H Cornel, R T van Domburg, A E Reijs, P R Nierop, P M Fioretti.   

Abstract

The aim of the study was to compare the extent and severity of reversible underperfusion in silent versus painful myocardial ischaemia during the dobutamine stress test. A consecutive series of 85 patients with significant coronary artery disease and reversible perfusion defects on technetium-99m methoxyisobutylisonitrile single-photon emission tomography performed at rest and during high-dose dobutamine stress (up to 40 microg kg-1 min-1) were studied. The left ventricle was divided into six segments. An ischaemic perfusion score was derived quantitatively by subtracting the rest from the stress defect score. Patients with multivessel disease had a higher ischaemic score (610+/-762 vs 310+/-411, P<0. 05) and a higher number of reversible perfusion defects (2.1+/-1.2 vs 1.1+/-0.8, P<0.01) than patients with single-vessel disease. Typical angina occurred in 37 patients (44%) during the test. There was no significant difference between patients with and patients without angina with respect to age, gender, peak rate-pressure product, prevalence of previous myocardial infarction, diabetes mellitus, multivessel disease or number of stenotic coronary arteries. Stress, rest and ischaemic scores as well as the number and distribution of reversible defects were not different in patients with and patients without angina. Patients with angina more frequently had a history of typical angina before the test (43% vs 17%, P<0.01) and ST-segment depression during the test (54% vs 25%, P<0.01). It is concluded that in patients with coronary artery disease and ischaemia detected by dobutamine scintigraphy, the extent and severity of coronary artery disease and myocardial perfusion abnormalities are similar with or without angina during stress testing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781140     DOI: 10.1007/bf01367591

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  30 in total

1.  Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography.

Authors:  J J Mahmarian; C M Pratt; M K Cocanougher; M S Verani
Journal:  Circulation       Date:  1990-10       Impact factor: 29.690

2.  Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing.

Authors:  J T Hays; J J Mahmarian; A J Cochran; M S Verani
Journal:  J Am Coll Cardiol       Date:  1993-06       Impact factor: 24.094

3.  Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease.

Authors:  T Forster; A J McNeill; A Salustri; A E Reijs; E S el-Said; J R Roelandt; P M Fioretti
Journal:  J Am Coll Cardiol       Date:  1993-06       Impact factor: 24.094

4.  Prevalence of and variables associated with silent myocardial ischemia on exercise thallium-201 stress testing.

Authors:  C M Gasperetti; L R Burwell; G A Beller
Journal:  J Am Coll Cardiol       Date:  1990-07       Impact factor: 24.094

5.  Left ventricular function in patients with coronary heart disease in the presence or absence of angina pectoris during exercise radionuclide ventriculography.

Authors:  A S Iskandrian; A H Hakki
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

6.  Dobutamine 99mTc-MIBI single-photon emission tomography: non-exercise-dependent detection of haemodynamically significant coronary artery stenoses.

Authors:  E Voth; F M Baer; P Theissen; C A Schneider; U Sechtem; H Schicha
Journal:  Eur J Nucl Med       Date:  1994-06

7.  Stress-induced left ventricular dysfunction in silent and symptomatic myocardial ischemia during dobutamine stress test.

Authors:  A Elhendy; M L Geleijnse; J R Roelandt; J H Cornel; R T van Domburg; P M Fioretti
Journal:  Am J Cardiol       Date:  1995-06-01       Impact factor: 2.778

8.  Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers.

Authors:  P M Fioretti; D Poldermans; A Salustri; T Forster; P Bellotti; E Boersma; A J McNeill; E S el-Said; J R Roelandt
Journal:  Eur Heart J       Date:  1994-03       Impact factor: 29.983

9.  Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography.

Authors:  T Marwick; B Willemart; A M D'Hondt; T Baudhuin; W Wijns; J M Detry; J Melin
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

10.  Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography.

Authors:  B Günalp; B Dokumaci; C Uyan; E Vardareli; E Işik; H Bayhan; M Ozgüven; E Oztürk
Journal:  J Nucl Med       Date:  1993-06       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.